In the present study,1H MRS was used to investigate potential dysregulations of
GABA and glutamatergic compounds in subjects at ultra-high risk (UHR)for schizophrenia compared to healthy
controls, and found higher levels of both neurotransmitters in the striatum
and medial prefrontal cortex of the UHR group.